Polaryx Therapeutics, Inc. (PLYX)

CIK 2075320 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Polaryx Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 20268-K0001213900-26-096235
Aug 13, 202610-Q0001213900-26-089118
Jul 28, 2026DEF 14A0001213900-26-082339
Jul 28, 2026DEFA14A0001213900-26-082345
Jul 28, 2026ARS0001213900-26-082353
Jul 24, 2026S-80001213900-26-081404
Jul 21, 20268-K0001213900-26-080041
Jul 17, 20268-K0001213900-26-078912
May 28, 20268-K0001213900-26-062155
May 28, 202640001213900-26-062322
May 15, 202610-Q0001213900-26-056973
Mar 24, 202610-K0001213900-26-033064
Feb 20, 202640001213900-26-018845
Feb 5, 2026SCHEDULE 13D0001213900-26-012759
Feb 2, 2026424B40001213900-26-010761
Jan 29, 202630001213900-26-009563
Jan 29, 202630001213900-26-009569
Jan 29, 202630001213900-26-009564
Jan 29, 202630001213900-26-009664
Jan 29, 2026EFFECT9999999995-26-000339
Jan 29, 202630001213900-26-009566
Jan 29, 202630001213900-26-009567
Jan 29, 202630001213900-26-009565
Jan 28, 2026CERT0001354457-26-000098
Jan 27, 20268-A12B0001213900-26-008173